PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
AID  - 10.1136/jitc-2023-007766corr1
DP  - 2024 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e007766corr1
VI  - 12
IP  - 7
4099  - http://jitc.bmj.com/content/12/7/e007766corr1.short
4100  - http://jitc.bmj.com/content/12/7/e007766corr1.full
SO  - J Immunother Cancer2024 Jul 01; 12